Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study-Reference-Cited by-同舟云学术

Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study

Published:2024-05 Issue: Volume:Volume 16 Page:203-215
ISSN:1179-1373
Container-title:HIV/AIDS - Research and Palliative Care
language:en
Short-container-title:HIV

Author:

Facha Wolde^ORCID,Tadesse Takele,Wolka Eskinder^ORCID,Astatkie Ayalew^ORCID

Publisher

Informa UK Limited

Reference52 articles.

1. World Health Organization. HIV and AIDS, Key Facts [Internet]; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed May 7, 2024.

2. World Health Organization. HIV statistics, globally and by WHO region, 2023. WHO, Epidemiological [Internet]; 2023:1–8. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/overview. Accessed May 7, 2024.

3. Medecins Sans Frontieres. Prevention of Mother-to-Child Transmission of HIV. Medecins Sans Frontieres; 2020:45.

4. FMoH. National Comprehensive PMTCT/MNCH Integrated Training Manual. Addis Ababa: FMoH; 2021:434.

5. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV infection: Recommendations for a Public Health Approach. WHO Press; 2013:251.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attrition from care and its predictors among women exposed to dolutegravir- and efavirenz-based first-line antiretroviral therapy in Ethiopia: a before-and-after study;Frontiers in Public Health;2024-07-02